The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta-analysis and trial sequential analysis.


Journal

Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272

Informations de publication

Date de publication:
Aug 2023
Historique:
revised: 20 04 2023
received: 31 01 2023
accepted: 08 05 2023
medline: 21 8 2023
pubmed: 21 6 2023
entrez: 21 6 2023
Statut: ppublish

Résumé

We assessed the effects of hypertonic saline solution (HSS) plus furosemide versus furosemide alone in patients with acute decompensated heart failure (ADHF). We searched four electronic databases for randomized controlled trials (RCTs) until June 30, 2022. The quality of evidence (QoE) was assessed using the GRADE approach. All meta-analyses were performed using a random-effects model. A trial sequential analysis (TSA) was also conducted for intermediate and biomarker outcomes. Ten RCTs involving 3013 patients were included. HSS plus furosemide significantly reduced the length of hospital stay (mean difference [MD]: -3.60 days; 95% confidence interval [CI]: -4.56 to -2.64; QoE: moderate), weight (MD: -2.34 kg; 95% CI: -3.15 to -1.53; QoE: moderate), serum creatinine (MD: -0.41 mg/dL; 95% CI: -0.49 to -0.33; QoE: low), and type-B natriuretic peptide (MD: -124.26 pg/mL; 95% CI: -207.97 to -40.54; QoE: low) compared to furosemide alone. HSS plus furosemide significantly increased urine output (MD: 528.57 mL/24 h; 95% CI: 431.90 to 625.23; QoE: moderate), serum Na

Identifiants

pubmed: 37340592
doi: 10.1002/clc.24033
pmc: PMC10436795
doi:

Substances chimiques

Diuretics 0
Furosemide 7LXU5N7ZO5
Saline Solution, Hypertonic 0
Sodium 9NEZ333N27

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

853-865

Informations de copyright

© 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.

Références

Adv Ther. 1999 Sep-Oct;16(5):219-28
pubmed: 10915397
Clin Cardiol. 2023 Aug;46(8):853-865
pubmed: 37340592
Int J Stroke. 2018 Aug;13(6):612-632
pubmed: 29786478
ESC Heart Fail. 2019 Jun;6(3):464-474
pubmed: 31021532
World J Cardiol. 2017 Aug 26;9(8):685-692
pubmed: 28932357
Eur J Heart Fail. 2019 Feb;21(2):137-155
pubmed: 30600580
JACC Heart Fail. 2020 Mar;8(3):157-168
pubmed: 31838029
Circ Res. 2021 May 14;128(10):1468-1486
pubmed: 33983837
Eur J Heart Fail. 2000 Sep;2(3):305-13
pubmed: 10938493
JACC Heart Fail. 2020 Mar;8(3):199-208
pubmed: 32035891
J Am Heart Assoc. 2017 Aug 3;6(8):
pubmed: 28775063
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
Eur Heart J. 2022 Feb 10;43(6):440-441
pubmed: 34922348
Adv Ther. 2015 Oct;32(10):971-82
pubmed: 26521190
Cardiology. 2001;96(3-4):132-43
pubmed: 11805380
ESC Heart Fail. 2020 Dec;7(6):4458-4464
pubmed: 32893505
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Cardiol Rev. 2021 Mar-Apr 01;29(2):73-81
pubmed: 32282394
Int J Cardiol. 2014 May 1;173(2):139-45
pubmed: 24679680
J Card Fail. 2011 Apr;17(4):331-9
pubmed: 21440872
J Am Coll Cardiol. 2017 Mar 21;69(11):1399-1406
pubmed: 27654854
Am J Med Sci. 2011 Jul;342(1):27-37
pubmed: 21701268
Int Heart J. 2017 Aug 3;58(4):601-607
pubmed: 28701670
Curr Heart Fail Rep. 2019 Apr;16(2):57-66
pubmed: 30762178
J Am Coll Cardiol. 2005 Jun 21;45(12):1997-2003
pubmed: 15963399
Hypertension. 2020 Oct;76(4):1045-1054
pubmed: 32829662
Eur Heart J Acute Cardiovasc Care. 2022 Feb 8;11(2):173-185
pubmed: 35040931
Am Heart J. 2003 Mar;145(3):459-66
pubmed: 12660669
Int J Cardiol. 2013 Jul 15;167(1):34-40
pubmed: 22243938
PLoS One. 2018 Nov 8;13(11):e0207242
pubmed: 30408132
J Am Coll Cardiol. 2020 Mar 17;75(10):1178-1195
pubmed: 32164892
Circulation. 2005 May 17;111(19):2454-60
pubmed: 15867182
Am Heart J. 2012 Sep;164(3):351-7
pubmed: 22980301
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Herz. 2015 Dec;40(8):1115-20
pubmed: 26135463
Eur Heart J Acute Cardiovasc Care. 2018 Jun;7(4):379-389
pubmed: 29897275
J Card Fail. 2014 May;20(5):295-301
pubmed: 24462960
Am J Cardiovasc Drugs. 2021 May;21(3):331-347
pubmed: 33210263
ESC Heart Fail. 2021 Oct;8(5):4174-4186
pubmed: 34288546
JACC Heart Fail. 2020 Mar;8(3):209-211
pubmed: 32035895
J Clin Endocrinol Metab. 1986 May;62(5):1003-10
pubmed: 2937798
Nat Rev Cardiol. 2020 Oct;17(10):641-655
pubmed: 32415147
Iran J Pharm Res. 2021 Summer;20(3):216-222
pubmed: 34903983
Acute Card Care. 2007;9(2):82-6
pubmed: 17573581
BMC Med Res Methodol. 2017 Mar 6;17(1):39
pubmed: 28264661

Auteurs

Carlos Diaz-Arocutipa (C)

Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.

Jack Denegri-Galvan (J)

Deparment of Cardiology, Hospital Nacional Daniel Alcides Carrión, Callao, Peru.

Lourdes Vicent (L)

Cardiology Department, Hospital Universitario 12 de Octubre and Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Marcos Pariona (M)

Department of Cardiology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.

Mamas A Mamas (MA)

Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Keele, UK.

Adrian V Hernandez (AV)

Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.
Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH